Vanessa Broadhurst is Company Group Chairman, Global Commercial Strategy Organization (GCSO) and is a member of the Pharmaceuticals Group Operating Committee.
Prior to being named to this role, Vanessa was President, Cardiovascular & Metabolism (CVM) and a member of the Janssen Americas Leadership Team. She also provided strategic oversight of the full portfolio of Janssen medicines in Puerto Rico and Canada.
Prior to her CVM role, Vanessa was General Manager for the Bone Health and Cardiovascular Business Unit at Amgen. Previously, she was responsible for the Inflammation and Cardiovascular Business Unit at Amgen.
Vanessa originally joined Janssen in 2005. As Worldwide Vice President, Anemia/Oncology Supportive Care, she developed the global strategy for the franchise and drove therapeutic area development and growth.
Vanessa is widely respected for her commitment to talent development and diversity & inclusion. In 2018, Vanessa was named Woman of Excellence and Healthcare Champion of the Year by the National Association for Female Executives (NAFE).
Vanessa earned an MBA degree from the University of Michigan, where she was a Consortium for Graduate Study in Management Fellow, and a BA degree from the University of Colorado.
